Increased circulating phenylacetylglutamine concentration elevates the predictive value of cardiovascular event risk in heart failure patientsHaoran Wei, Dao Wen Wang, Chenze Li et al.|Journal of Internal Medicine|2023Cited by 28
Gut microbiota-dependent phenylacetylglutamine in cardiovascular disease: current knowledge and new insightsYaonan Song, Dao Wen Wang, Haoran Wei et al.|Frontiers of Medicine|2024Cited by 27